menu
    • menu

    Company profile for Tedor Pharma

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tedor Pharma Inc. offers pharmaceutical product development through commercialization services for your IND, NDA or ANDA needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tedor PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Tedor Pharma Inc., 400 Highland Corporate Drive, Cumberland, RI 02864, USA
    Telephone
    Telephone
    401 658 5219
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://tedorpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tedor Pharma, Cardinal Health Form Collaboration
    Tedor Pharma, Cardinal Health Form Collaboration

    04 Jun 2020

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2020-06-04/tedor-pharma-cardinal-health-form-collaboration/

    CONTRACTPHARMA
    04 Jun 2020
    Share Share
    TEDOR Pharma Appoints Regional BD Director
    TEDOR Pharma Appoints Regional BD Director

    20 Jan 2020

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2020-01-21/tedor-pharma-appoints-regional-bd-director/

    CONTRACT PHARMA
    20 Jan 2020
    Share Share
    Tedor Pharma Announces Agreement to Mfg. Sequential Medicine Ltd.
    Tedor Pharma Announces Agreement to Mfg. Sequential Medicine Ltd.

    17 Oct 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tedor-pharma-announces-agreement-to-manufacture-sequential-medicine-ltd-phase-2-clinical-trial-supplies-300939360.html

    PR NEWSWIRE
    17 Oct 2019
    Share Share
    Tedor, Sequential Enter Clinical Manufacturing Pact
    Tedor, Sequential Enter Clinical Manufacturing Pact

    16 Oct 2019

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2019-10-15/tedor-sequential-enter-clinical-manufacturing-pact/

    CONTRACT PHARMA
    16 Oct 2019
    Share Share
    TEDOR Pharma Announces Recapitalization and New Management
    TEDOR Pharma Announces Recapitalization and New Management

    16 May 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tedor-pharma-announces-recapitalization-and-new-management-300649422.html

    PR NEWSWIRE
    16 May 2018
    Share Share
    Tedor Pharma's Generic Acetaminophen; Butalbital; Caffeine Receives Approval in US
    Tedor Pharma's Generic Acetaminophen; Butalbital; Caffeine Receives Approval in US

    08 Aug 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206615

    FDA
    08 Aug 2017
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search